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One critical element to optimize funding decisions involves the cost and efficiency implica-
tions of implementing alternative program components and configurations. Program plan-
ners, policy makers and funders alike are in need of relevant, strategic data and analyses to
help them plan and implement effective and efficient programs. Contrary to widely accepted
conceptions in both policy and academic arenas, average costs per service (so-called "unit
costs") vary considerably across implementation settings and facilities. The objective of this
work is twofold: 1) to estimate the variation of VMMC unit costs across service delivery plat-
forms (SDP) in Sub-Saharan countries, and 2) to develop and validate a strategy to extrapo-
late unit costs to settings for which no data exists.
Methods
We identified high-quality VMMC cost studies through a literature review. Authors were con-
tacted to request the facility-level datasets (primary data) underlying their results. We stan-
dardized the disparate datasets into an aggregated database which included 228 facilities in
eight countries. We estimated multivariate models to assess the correlation between VMMC
unit costs and scale, while simultaneously accounting for the influence of the SDP (which
we defined as all possible combinations of type of facility, ownership, urbanicity, and coun-
try), on the unit cost variation. We defined SDP as any combination of such four characteris-
tics. Finally, we extrapolated VMMC unit costs for all SDPs in 13 countries, including those
not contained in our dataset.
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Results
The average unit cost was 73 USD (IQR: 28.3, 100.7). South Africa showed the highest
within-country cost variation, as well as the highest mean unit cost (135 USD). Uganda and
Namibia had minimal within-country cost variation, and Uganda had the lowest mean
VMMC unit cost (22 USD). Our results showed evidence consistent with economies of
scale. Private ownership and Hospitals were significant determinants of higher unit costs.
By identifying key cost drivers, including country- and facility-level characteristics, as well as
the effects of scale we developed econometric models to estimate unit cost curves for
VMMC services in a variety of clinical and geographical settings.
Conclusion
While our study did not produce new empirical data, our results did increase by a tenfold the
availability of unit costs estimates for 128 SDPs in 14 priority countries for VMMC. It is to our
knowledge, the most comprehensive analysis of VMMC unit costs to date. Furthermore, we
provide a proof of concept of the ability to generate predictive cost estimates for settings
where empirical data does not exist.
Introduction
HIV continues to be a major public health challenge with global repercussions for domestic
health systems and international donor agencies [1]. In 2016, an estimated 36.7 million people
were living with HIV, [2]. In the same year, there were 1.7 million new HIV infections, with
more than two-thirds occurring in sub-Saharan Africa [1].
Strategies to prevent HIV transmission are imperative to continue progress toward reduc-
ing HIV infections. Program planners, policy makers and funders alike are in need of relevant,
strategic data and analyses to help them plan and implement effective and efficient programs.
Maximizing health benefits given the increasing insufficiency of available funds is now more
urgent than ever.
One critical element to optimize funding decisions involves the cost and efficiency implica-
tions of implementing alternative program components and configurations. Contrary to
widely accepted conceptions in both policy and academic arenas, average costs per service (so-
called "unit costs") vary considerably across implementation settings and facilities [3–7]. The
factors behind this variation are complex and include both justifiable and systematic causes, as
well as health system inefficiencies and waste. Yet, most of the policy-oriented literature on
costs and cost-effectiveness continues to rely on the conception of one single unit cost to make
recommendations, plan scaling-up of programs, and assess efficiency. As a consequence, deci-
sion-makers continue to make policy decisions based on often misconceived and flawed cost
data and assumptions.
The policy relevance of cost information hinges on its accessibility and availability in a
timely fashion. However, costing studies that appropriately measure costs and assess cost vari-
ation are scarce. Additionally, funding and time limitations restrict the type, quality, and quan-
tity of studies. And yet, the need for such information is growing as global funding for HIV
programs shrinks and rates of new HIV infections remain stubbornly high [8].
A strategy is needed to address these challenges. The objective of this work, which is part of
the Global Health Cost Consortium (GHCC) initiative [9,10], was to use facility-level cost data
to model unit costs curves of Voluntary Medical Male Circumcision (VMMC) services for a
PLOS ONE Moving away from the "unit cost." Predicting country-specific average cost curves of VMMC
PLOS ONE | https://doi.org/10.1371/journal.pone.0249076 April 22, 2021 2 / 17
design, data collection and analysis, decision to
publish, or preparation of the manuscript? No, the
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript. Coauthors Forsythe S, Tchuenche
M, and Bollinger LA are employed by Avenir Health
and Chiwevu C is an independent consultant.
Avenir Health did not have a role in the study. The
funder provided support in the form of salaries for
BLA, but did not have any additional role in the
study design, data collection and analysis, decision
to publish, or preparation of the manuscript. The
specific roles of these authors are articulated in the
‘author contributions’ section.
Competing interests: All authors declare no
conflict of interest. Coauthors Forsythe S,
Tchuenche M, and Bollinger LA are employed by
Avenir Health and Chiwevu C is an independent
consultant. This does not alter our adherence to
PLOS ONE policies on sharing data and materials.
Abbreviations: GHCC, Global Health Cost
Consortium; GLM, Generalized Linear Models;
OLS, Ordinary Least Squares; SDP, Service
Delivery Platform; VMMC, Voluntary Medical Male
Circumcision.
variety of implementation settings. Specifically, our aim is twofold: 1) to explicitly account for
the effect of service delivery platforms on the variation of VMMC unit costs and 2) to develop
a strategy to extrapolate unit costs to settings for which no data exists.
Methods
The Global Health Cost Consortium
The Global Health Cost Consortium was a three-year project funded by the Bill and Melinda
Gates Foundation which aimed to increase the efficiency and effectiveness of HIV and TB pre-
vention and treatment by curating and facilitating access to available cost data, and producing
standards for future cost data collection and analysis. As part of the GHCC objectives, we
intended to inform the development of methods to estimate unit costs of various interventions
and settings, while explicitly accounting for critical parameters describing service delivery plat-
forms and delivery settings. Ultimately, our approach seeks to produce vital information to
program planners, policymakers, funders and academics.
Voluntary medical male circumcision
Voluntary medical male circumcision has been shown to be an effective intervention to reduce
HIV transmission [11,12]. Several studies, including randomized controlled trials (RCT), have
demonstrated that VMMC reduces HIV transmission by up to 60% and decreases the risk of
other sexually transmitted infections (STI) in men and their female partners [11,13–15]. When
combined with other evidence-based prevention and treatment methods, studies have shown
that VMMC reduces new HIV infections even further [16].
Based on the well-documented benefits of VMMC, the World Health Organization (WHO)
has recommended the scale-up of VMMC in high HIV prevalence countries. In 2011, the
WHO and UNAIDS set a target of reaching 80% VMMC coverage for adult males in 13 prior-
ity African countries by 2015, including Botswana, Kenya, Lesotho, Malawi, Mozambique,
Namibia, Rwanda, South Africa, Swaziland, Uganda, Tanzania, Zambia, and Zimbabwe [17].
While some of these countries are close to the target, not all of them have yet reached the
threshhold [18]. Furthermore, recent investment cases for preventing HIV and policy analyses
to support Universal Health Coverage interventions, include VMMC as part of an essential
package of interventions [19,20].
Overview of methods
We developed a multi-stage approach using several data sources. First, we identified relevant
VMMC costing studies through a systematic review of the literature [9]. Second, we contacted
authors of selected papers to request the facility-level datasets (primary data) underlying their
results, while simultaneously extracting cost estimates (secondary data) from all publications.
Third, we standardized both primary and secondary data for joint analyses. Fourth, we mod-
eled VMMC costs curves to predict the relationship between unit costs and scale for distinct
service delivery platforms. Finally, we extrapolated VMMC cost curves for service delivery
platforms outside our sample of countries.
Identifying VMMC studies
Our anslysis uses empirical data from twenty-nine VMMC costing studies identified through
an extensive literature review [9]. The initial systematic search included several HIV interven-
tions (e.g., VMMC, antiretroviral treatment, pre-exposure prophylaxis, etc.). For this analysis,
we selected only VMMC costing studies. The systematic search of databases was conducted for
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studies published between January 2006 and October 2017, and included Web of Science,
Cochrane, PubMed, Embase, NHS EED, LILACS, Google Scholar, several gray literature
resources and snowball searching. The initial search yielded 23,938 documents. Of these, 2,566
published and gray literature studies were identified and assessed for inclusion in the study.
We identified 58 studies reporting costing information on VMMC interventions. Finally, we
selected 29 studies for inclusion after removing papers reporting modeled cost data, those with
insufficient or incomplete costs results, or those with duplicate information.
Requesting data
We compiled data sets from multiple studies directly from their authors. Following a standard
protocol (S1 Fig), we requested primary data from reports and papers which met the following
additional inclusion criteria: i) facility-level data and ii) sample size greater than one site. Of
the twenty-nine original VMMC studies, fifteen met these additional inclusion criteria. We
contacted two authors from each paper to request the underlying primary data; typically, the
corresponding and the first authors. The authors from eight studies declined to collaborate or
did not answer, narrowing our final primary data sample to seven studies, comprising 238
facilities across eight countries.
Of the 238 facilities, 220 had complete information. The studies covered the years 2008 to
2013, with various data collection dates. We requested the following data elements for each
paper, at the facility level: total cost and total cost disaggregated by input categories (personnel,
capital, recurrent and other); total unit cost and unit cost disaggregated by cost categories; out-
puts (total annual number of male circumcisions performed); facility characteristics including
facility type, ownership, and urbanicity; and outreach models, i.e., fixed (facility-based) vs. out-
reach (mobile services).
Extracting data from published costing studies
Extraction of data from published and gray literature articles was conducted using a standar-
dardized strategy across all interventions and disease areas and is explained in greater detail
elsewhere [9]. Breifly, all VMMC studies identified during our sysetmatic search and screening
process were dividied among three extractors who recorded relevant cost and study attribute
information and recorded it into a common format with each observation (row) representing
a unique VMMC unit cost. Version control was managed by a lead data manager, each variable
was examined for outliers that might suggest potential transcription errors and each observa-
tion was double-checked for accuracy and quality by a senior researcher. Any discrepancies
were reconciled by the original extractor, lead data manager and senior researcher.
Standardizing data
Primary data. Primary data consisted of disparate datasets received directly from study
authors which we combined into an harmonized dataset. We used a standardization process as
follows: 1) We transfered each dataset into a flat (horizontally oriented), facility-level dataset;
2) we filled-in a study-specific codebook with critical variables; 3) we standarded the input
cost categories across data sources; 4) we concatenated the separate cleaned datasets into one
final analytic dataset. All analyses were conducted using Stata SE version 15. See more details
on S1 File, Standardization Process.
All the cost data were converted from local currencies to United States dollars (USD) using
exchange rates reported by the World Bank according to the year of data collection. We
inflated all costs to 2016 using the gross domestic product (GDP) Implicit Price Deflator meth-
odology [21].
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Secondary data. We extracted published unit cost data from the literature review to create
a complementary data set, hereafter referred to as ’secondary data.’ We standardized secondary
data previously extracted from publications for those studies whose authors either declined to
share their primary data, did not respond to our emails, or did not meet inclusion criteria. As
with primary data, secondary data were standardized by exchanging local currencies to US
Dollars and then inflated to 2016 USD using the United States’ GDP Implicit Price Deflator
[21].
Authors typically reported a single unit cost reflecting the average unit costs across several
sites (mostly facilities). In the case of the two studies from Kenya, the GHCC team extracted
six unit cost observations which resulted from averages across 251 platforms throughout the
country [22]. We excluded observations due to two main reasons: underestimation of the total
unit costs due to missing input costs; i.e., studies that failed to measure critical inputs such as
staff; and unit costs that resulted from averaging facility-level unit costs from a mixed sample
of facilities regarding urbanicity, ownership or type of facility.
Pooled data—Aggregation of data to the level of service delivery platform
For the final stage of the analysis we aggregated or collapsed the facility-level primary data to
the level of SDP, in order to produce SDP-level exptrapolations. Our primary data set was
reduced from 220 facility-level unit costs to 38 SDP-level unit costs after collapsing, plus an
additional nine observations from two countries from secondary data. See S2 Fig. for a descrip-
tion of the process of collapsing data, and S1 Table for a list of SDPs. The pooled dataset was
comprised of 47 unit costs derived from 16 different studies (seven primary studies and nine
published papers).
Defining service delivery platforms (SDP)
Overall, primary data included facility-level cost estimates for eight countries, across a wide
range of delivery strategies and settings. We standardized the definitions of those setting char-
acteristics according to three mutually exclusive categories:
i. the type of facility (clinic or hospital),
ii. ownership (public or private), and
iii. urbanicity (urban or rural).
We then defined a service delivery platform (SDP) as any given combination of those three
categories in each country in our sample. For example, one service delivery platform might be
public, rural clinics in Kenya. Another would be private, urban hospitals in Nigeria; or public,
rural hospitals in South Africa, and so forth. We were able to define 64 different service deliv-
ery platforms across eight countries. Secondary data comprised SDP-level estimates of unit
costs across 6 countries, with a total of 9 observations (see S1 Fig).
Definition of unit costs
To measure unit costs of VMMC, we included three broad input cost categories—capital,
recurrent, and personnel. We defined capital costs as non-consumable goods lasting over one
year, such as equipment and vehicles; recurrent costs as consumable supplies (e.g., HIV test
and disposable circumcision kits), maintenance expenses, utilities, and training; and personnel
costs as salaries of direct medical staff (physicians and nurses), and other non-medical staff
(managers, supervisors, and ancillaries). The total cost of VMMC for each facility was defined
as the sum of capital, recurrent and personnel costs. The VMMC unit cost, was the facility-
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level average cost per circumcision, i.e., the total annual cost VMMC divided by the total num-
ber of male circumcisions performed (See S1 File).
We also extracted the unit costs secondary data as reported in the publications. During the
standardization process we confirmed that the descriptions of the unit costs definitions were
consistent with ours. Given that the published estudies identified used a similar definition of
unit costs, chages were not required.
Analysis
Primary data analysis–unit cost curve. We used Ordinary Least Squares (OLS) and Gen-
eralized Linear Models (GLM) to model facility-level unit cost curves with respect to scale. In
particular, we estimated multivariate models to assess the correlation between VMMC unit
costs and scale, while simultaneously accounting for the influence of the type of facility, owner-
ship, urbanicity, and country, on the unit cost variation in our sample.
The dependent variable in the OLS regression models was the natural logarithm of the facil-
ity-level average cost per male circumcision (unit cost). In GLM regressions we used the unit
cost per male circumcision with a gamma family and log link function [23]. The independent
variable was scale (number of VMMC per year), operationalized as a continuous independent
variable. We also tested for non-linearities using higher order scale parameters.
To ensure that our regression coefficients were robust, we explored different model specifi-
cations. We controlled for urbanicity, ownership, type of facility, outreach, and 2016 GDP per
capita. Based on the Akaike information criteria (AIC) and Bayesian information criteria
(BIC) we selected the best-fitted model [24]. We also used the F-statistic to explore differences
in model performance after removing non-significant variables. We also tested for heteroske-
dasticity in all models.
We explored the presence of multicollinearity with the variance inflation factor (VIF) to
ensure OLS models were appropriate. We also performed sensitivity analyses using GLM mod-
els on the same regression specifications as OLS to test for robustness. The differences between
OLS and GLM models were negligible. We present the final model specification we used in Eq
1:
lnðUCicÞ ¼ aþ b1Sic þ b2S
2
ic þ b3Tic þ b4Oic þ b5Uic þ b6Dic þ b7GDPc þ b8Yic þ b9Tic
� Oic ð1Þ
Where UCic is the average annual cost per VMMC performed in facility i, in country c. Sic
is the annual number of VMMCs performed in facility i, in country c. Tic (facility type) takes
the value 1 if hospital and 0 if clinic. Oic (ownership) takes the value 1 if the facility is private
and 0 if public. Uic (urbanicity) takes the value 1 if the facility is located in a rural area and 0 if
urban. Dic (delivery model) equals 1 if outreach and 0 if the service was fixed. GDPc is the 2016
GDP per capita in country c. Yic is the year of data collection for each study. In addition, we
included an interaction term between facility type and ownership.
Pooled data analysis—Extrapolation of unit cost curves
The goal of the second analytic approach was to predict VMMC unit costs for any SDP in 13
countries, including those not contained in our dataset. We followed a similar process to select
the best model specification for extrapolating unit costs as the one we used for the unit cost
curves analysis described above. We examined different specifications using both OLS and
GLM, exploring non-linearities and interactions and compared their relative performance
based on AIC and BIC criteria. We also tested for multicollinearity with the VIF parameter. In
addition to including the variables defining the service delivery platforms–GDP per capita,
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type of facility, ownership, and urbanicity; we explored additional variables describing the con-
text at the country level, including economic, health system, and epidemiological characteris-
tics. The final specification used for the extrapolation analysis is defined by Eq 2:
lnðUCscÞ ¼ aþ b1GDPc þ b2Tsc þ b3Osc þ b4Usc þ b5Covc þ b6Rc ð2Þ
Where UCSC is the average annual cost per VMMC in SDP s, in country c. Tsc, Osc, and Usc
correspond to facility type, ownership, and urbanicity, respectively, for SDP s, in country c.
GDPc is the 2016 GDP per capita in country c, Covc is the VMMC coverage (proportion of
adult men covered by MC) in country c, and Rc is a health personnel salary index in country c
taken from [25].
We validated the extrapolations at the country level by iteratively removing one country
from the dataset, running the regression in Eq 2 with the remaining data, predicting the unit
costs for all SDPs in the excluded country using the results from our regression, and then com-
paring the predicted values to the observed values. Finally, we computed several measures of
performance of these comparisons to evaluate the accuracy of the extrapolations.
Results
Data
Table 1 shows the descriptive statistics of the primary, secondary, and pooled data sets. We
present primary data both at the facility level (column 1), and the SDP level (column 2). Sec-
ondary data exists only at the SDP level (column 3). There are 220 observations in the primary
dataset, which represent 38 SDP scenarios once we collapsed the data. We obtained an addi-
tional nine SDP observations from secondary data. Once we pooled both sources, there are 47
observations at the SDP level (column 4).
Collapsing primary data did not significantly change the average unit cost per VMMC (USD
66 at the facility level vs. USD 64 at the SDP level). The average unit cost from secondary data is
also similar to that of the primary data (USD 69). The distribution of the sample concerning urba-
nicity, ownership, and type of facility was also stable (columns 1 and 2). While the sample is bal-
anced in terms of urbanicity in primary data, the majority of the facilities in secondary data
belong to urban areas (77%). Private facilities represented 37% and 33% in primary and secondary
data, respectively. Finally, there is a balanced proportion of hospitals and clinics in primary data
(52% and 47%, respectively), whereas hospitals are overrepresented in secondary data (66%).
The main limitation of the secondary data was that the number of VMMCs performed per
year (scale) was infrequently reported in the papers. However, we were able to include unit
costs from two additional countries using this source in the pooled data.
We found substantial variation in the average cost per male circumcision, both within and
across countries. South Africa showed the highest within-country unit cost variation, as well as
the highest median unit cost. Uganda and Namibia showed the minimum within-country unit
cost variation, and the lowest median VMMC unit cost was observed in Uganda. We present
the distribution of unit costs for each country in S3 Fig.
Determinants of VMMC unit cost variation—Estimation of unit cost curves
In this section, our primary objective is to describe the association between VMMC unit costs
and scale–measured by the annual number of circumcisions performed per facility. Secondly,
we explored how facility-level characteristics mediate this relationship.
Table 2 presents the results of OLS (column 1) and GLM (column 2) regression models
with the facility-level unit cost per circumcision as the dependent variable and the scale and
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facility-level features, as well as country-level per capita GDP as independent variables. The
models control for the year in which each study’s data collection took place to capture possible
technological progress or system-level experience. We determined the model specification
with the best fit using AIC and BIC statistical criteria. The OLS model showed a R-squared
parameter of 0.56.
In both models, the coefficient for scale shows a significant and negative association with
unit costs, which is consistent with economies of scale; for every 10% increase in the annual
number of male circumcisions, the unit costs were 1.5% lower on average. The coefficient for
scale squared was not statistically significant.
The coefficient for the country-level indicator GDP per capita is statistically significant,
with a positive association with unit costs. For a 10% increase in annual GDP per capita, there
was an associated 5% higher unit cost, on average, holding everything else constant.
To assess the influence of urbanicity, ownership, and type of facility on unit costs, we
assume that those characteristics shift the unit cost curve with respect to scale. While the coef-
ficient of urbanicity is not statistically significant, the coefficient for ownership shows a potitive
Table 1. Description of data–primary, secondary and pooled data.
(1) Primary data (2) Aggregated primary data1 (3) Secondary Data2 (4) Pooled data3
Observations 220 38 9 47
Urbanicity
Rural Facilities (%) 50 50 23 45
Urban Facilities (%) 50 50 77 55
Ownership
Private facilities (%) 36 36 33 36
Public facilities (%) 64 64 67 64
Facility type
Hospitals (%) 47 53 66 55
Clinics (%) 53 47 34 45
Outreach
Outreach (%) 13 – – –
Fixed (%) 87 – – –
Unit cost4 (SD5) 66(59) 64(48) 69(44) 65(47)
Average number of VMMC per year (SD) 1,097(1,796) 1,212(2,056) – –
Average VMMC coverage (SD) 49(30) 44(30) 30(27) 41(30)
Average GDP per capita (SD) 2,252(1,893) 1,995(1,813) 2,736(2,786) 2,137(2,020)
Median of data collection year 2013 2012 2013 2013
Average health personnel salary index6 (SD) 0.32(0.14) 0.3(0.13) 0.28(0.1) 0.3(0.13)
Number of studies 7 7 9 16
Average number of facilities per observation 1 6 5 5
Number of countries represented 8 8 6 10
Notes.
1. Aggregated primary data, collapsed at the SDP level.
2. Unit cost observations extracted from the literature review.
3. Combined aggregated primary data and secondary data (columns 2 + 3).
4. Unit costs are reported in 2016 USD.
5. Standard deviation.
6. Compensation index estimated by The International Comparison Program (ICP) using purchasing power parities (PPPs) to compare the size and price (wage) levels
of health personnel around the world [25].
https://doi.org/10.1371/journal.pone.0249076.t001
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association between unit costs and private facilities compared to public ones–an average 25%
higher unit costs in the former compared to the latter. The type of facility also shifts upwards
the cost curve–about 60% in hospitals compared to clinics. Facilities conducting outreach are,
on average, 30% costlier than those with fixed services. We also observed a positive time trend
in unit costs, with a 15% average increase per year.
In Fig 1, we display the results of the OLS regression model presented in Table 2, graphi-
cally. We show the results for the full sample and by country–we ordered countries by magni-
tude of VMMC unit costs from the most expensive (South Africa) to the least expensive
(Uganda).
The unit cost curves describe the relationship between unit costs and scale resulting from
the regression results. Each line represents a facility-level unit cost curve for a specific SDP.
The curves shift upwards and downwards depending on the combination of implementing fea-
tures. Given that the interaction between scale and GDP was not statistically significant, all
curves are parallel.
The dots on the graphs represent the empirically measured facility-level unit costs–i.e., each
dot represents a facility in the sample, and the observed unit cost and specific level of scale
observed in the facility determine their position in the graph. The extent to which the curves
Table 2. Regression models on the determinants of VMMC unit cost variations. The Dependent Variable is the
Logarithm of the Facility-Level VMMC Unit Cost.
Variables (1) OLS1 (2) GLM2
Scale (log of annual number of VMMC) -0.13��� -0.15���
(0.03) (0.03)
Scale2 (log2 of annual number of VMMC) -0.007 -0.008
(0.01) (0.01)
GDP per capita 2016 (log) 0.56��� 0.49���
(0.06) (0.06)
Urbanicity (Rural = 1, Urban = 0) 0.01 0.004
(0.07) (0.09)
Ownership (Private = 1, Public = 0) 0.27�� 0.16
(0.12) (0.13)
Type of Facility (Hospital = 1, Clinic = 0) 0.61��� 0.62���
(0.11) (0.11)
Outreach (Outreach = 1, Fixed = 0) 0.27�� 0.29��
(0.12) (0.13)
Year of data collection (Ref: 2016) 0.14��� 0.18���
(0.02) (0.03)
Type of facility � Ownership -0.52��� -0.53���
(0.16) (0.18)
Constant 4.13��� 4.49���
Observations (Number of facilities) 220 220
Notes.





1. Ordinary Least Squares regression.
2. Generalized Linear Model. The model used a gamma family and log link function.
https://doi.org/10.1371/journal.pone.0249076.t002
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(and their confidence intervals, not shown) overlap with the individual facilities, varies by
country. However, most of the dots do overlap with the position of the curves, with Tanzania
showing the best fit and Rwanda the worst.
This result is likely related to the fact that some countries experienced considerably more
within heterogeneity, such as Zambia and Rwanda. Another critical aspect is the sample size
per country. As indicated in the graphs, our primary dataset contained relatively large samples
of facilities for some countries (South African, Kenya, Rwanda, Zambia, and Uganda), while
relatively small samples for other (Zimbabwe, Namibia, and Tanzania).
Since our variable for urbanicity has an almost negligible influence on costs, overall, the
curves for urban vs. rural scenarios overlap. However, other reported characteristics have a vis-
ibly higher impact. Private clinics show the highest costs, followed by public and private hospi-
tals. Public clinics are the least costly facilities.
Extrapolations of VMMC unit costs
Table 3 presents the results of the extrapolation models using the pooled dataset at the SDP-
level. We tested both OLS and GLM regression models. To identify the best-performing
Fig 1. VMMC unit cost curves by country. Notes. Each panel presents the estimated cost curves for each service delivery platform defined as the combination
of facility type, urbanicity, and ownership for each country, as indicated by the color guide. The panels also present the observed values of unit costs for each
country.
https://doi.org/10.1371/journal.pone.0249076.g001
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specification of the model, we tested several alternatives and then reviewed BIC and AIC
parameters to evaluate model fit. Overall, we found minimal differences between the OLS and
the GLM results. OLS produced lower standard errors than GLM. Since extrapolation models
are not necessarily the best-fitted models, we also tested the performance of predictions [26],
and OLS predictions were, on average, more accurate than GLM’s.
We found the coefficients of GDP per capita and the HSSI to be highly significant. Both are
positively associated with higher costs, which supports the conventional expectations that
countries with higher socioeconomic status and higher wages exhibit higher VMMC unit
costs. Although the coefficients for the other independent variables were not statistically signif-
icant, we still used those coefficients for the extrapolations. Overall, the OLS model explained
69% of the variability in costs across SDP.
To test the validity of the extrapolation models, we assessed the accuracy of the predicted
unit costs. As explained before, in an iterative process, we removed all the observations of one
country from the sample, then we re-ran the regression model to obtain new coefficients, and
predicted the unit costs for each removed country. Finally, we compared these predictions to
the observed values. We followed this process for each country in the sample. The results are
presented in Fig 2. For each country, the vertical axis measures the observed unit cost, and the
Table 3. Extrapolation regression models–dependent variable is SDP-Level VMMC unit cost.
Variables (1) OLS1 (2) GLM2
GDP per capita 2016 (log) 0.47��� 0.44���
(0.09) (0.08)
Urbanicity (Rural = 1, Urban = 0) 0.10 0.10
(0.11) (0.13)
Ownership (Private = 1, Public = 0) 0.14 0.09
(0.11) (0.14)
Type of Facility (Hospital = 1, Clinic = 0) 0.14 0.10
(0.12) (0.13)
Health Sector Salary Index (USD)3 2.55��� 2.84���
(0.75) (0.60)




Observations (SDP4) 47 47
R-squared 0.68
Notes.





1. Ordinary Least Squares regression.
2. Generalized Linear Model. The model used a gamma family and log link function.
3. Compensation index estimated by The International Comparison Program (ICP) using purchasing power parities
(PPPs) to compare the size and price levels of health personnel around the world [25].
4. Service Delivery Platform (SDP) is any given combination of three categories (facility type, urbanicity and
ownership) in each country in our sample.
https://doi.org/10.1371/journal.pone.0249076.t003
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horizontal axis the predicted unit cost. The 45-degree line identifies perfect predictions. Over-
all, 90% of our predictions were not statistically different from the observed values, and the
median error (in dollars) was USD 9.5, which represents 14% of the average unit cost (USD
65). Errors were higher as the unit costs increased. Using this approach, we produced estimates
for all possible SDPs (112 combinations) in the 14 priority countries for VMMC in Africa,
where only 10% of the SDPs had published estimations. We present the estimates in S2 Table.
Discussion
This analysis builds upon published VMMC studies and available facility level data to create
robust cost estimates for VMMC services in Sub-Saharan Africa. Using data from 16 VMMC
studies, we developed econometric models to estimate unit cost curves for VMMC services in
a variety of clinical and geographical settings. By identifying key cost drivers, including coun-
try- and facility-level characteristics, as well as the effects of scale, we projected VMMC unit
costs for several implementation settings, including many for which there are currently no
such data. Furtermore, our approach produces unit costs estimates with variance parameters,
Fig 2. Validation of extrapolated VMMC unit cost.
https://doi.org/10.1371/journal.pone.0249076.g002
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which allows to explicitly account for uncertainty, unlike the currently used approach which
overwhelmingly relies on point estimates with no information on uncertainty.
We studied unit costs in two distinct ways. First, we modeled VMMC unit costs in a sample
of 220 facilities in eight countries as a function of a variety of facility-level characteristics or
service delivery models (SDM), namely the type of facility, urbanicity, ownership, and scale
(number of VMMC performed per year). Secondly, we extrapolated unit cost estimates for
countries outside our sample and validated our predictions systematically in ten countries.
Overall, our results showed a high level of accuracy, with a median percentage error of 18%
between observed and predicted costs.
While our study did not produce new empirical data, our results did increase by a tenfold
the availability of unit costs estimates for 128 SDPs in 14 priority countries for VMMC. It is to
our knowledge, the most comprehensive analysis of VMMC unit costs to date. Furthermore,
we provide a proof of concept of the ability to generate predictive cost estimates for settings
where empirical data does not exist, leveraging previously published studies. Our relatively
large and diverse sample size enabled us to develop statistically significant cost estimates
accounting for a variety of context characteristics while taking into account the effect of scale
on cost variations. The latter is a crucial economic aspect largely absent in most of the costing
literature. Our approach contributes not only with additional information for VMMC pro-
grams but also serves as a guide for using existing cost data to create econometric models of
unit costs for other interventions and diseases.
Cost-effective interventions are essential in maximizing the impact of limited resources in
curbing the HIV epidemic in sub-Saharan Africa. Furthermore, funders, policy-makers, and
decision-makers all need accurate data on the economics of program implementation to
inform decisions. A timely, reliable, and precise description of the unit costs of services is,
therefore, a critical resource for them. Our research also has the potential to inform researchers
developing mathematical models on the impact of the HIV response on curbing the epidemic
and reaching global targets of coverage and impact.
One goal was to identify which facility-level variables significantly influence VMMC unit
costs. We were limited in this respect by the subset of variables included in all studies. Despite
this limitation, we were able to analyze critical facility-level characteristics. Overall, the most
statistically significant features our analysis found were the type of facility (hospital vs. clinic),
ownership (public vs. private), scale, and the year of data collection. Urbanicity and whether
or not the facility conducted outreach showed no statistically significant association with unit
cost variations.
Consistent with previous research [27–29], we found evidence consistent with the existence
of economies of scale in the provision of VMMC services–decreasing unit costs as the number
of services produced increased. The correlation was robust and statistically significant across
all the models tested, with an estimated 12% to 22% reduction in unit costs associated with a
ten percent increase in the size of service production. The lack of significance in the coefficient
of the squared term of the scale indicates that the percentage of reduction in unit cost remains
constant throughout the range of our data. Understanding the interaction between unit costs
and scale and moving away from the misleading notion of "the unit cost" as a fixed feature of
health services is vital.
Limitations
Readers should interpret the results from this study in light of several limitations. The primary
shortcoming stems from the fact that we used exclusively previously published data, and we
could not control study design, measurement methods, or the analysis and estimation of unit
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costs. The implications are potentially significant. The most immediate implication is that we
inherited the flaws and limitations of the original studies. The design of the research projects
included in the analysis necessarily constrained our results’ external and internal validity. Sec-
ondly, the studies’ quality is most likely uneven, resulting in systematic bias across countries.
Third, relying on previously published studies also implies that we combined observations not
originally meant to be analyzed together, which has statistical implications and means that
measurement methods were not necessarily consistent. Different measurement and estimation
methods could compromise comparability across studies. Fourth, the final sample is con-
strained to the countries and programs studied and published before. We addressed these chal-
lenges in various steps. We addressed the first, second, and third implications mentioned
above by using a systematic literature review to select studies. We used inclusion and exclusion
criteria to ensure a minimum level of quality in the studies selected and criteria to warrant
comparability of the results, such as rigorous measurement methods and exclusion of non-
empirical cost estimations. We discarded several studies and observations from the analysis
due to ambiguous, unclear, or inconsistent definitions reported by original study authors. We
also followed a rigorous process to standardize the definitions and measurement of all vari-
ables included in the analyses, including categories of inputs and costs, total costs, and facility
characteristics. The fourth implication above is impossible to address directly; however, the
extrapolation analysis’s objective was precisely to fill such gaps in data.
Another limitation of the study is that our definition of "service delivery platforms" was
constrained by the characteristics measured by all the original studies; therefore, we could
have omitted characteristics relevant for efficiency not captured in our data. We used combi-
nations of type of facility, urbanicity, and ownership to define platforms. To the extent that
other features are critical for efficiency and, therefore, for unit costs, our definition is incom-
plete and our results potentially biased. For example, we did not include staff size and staff
composition measures, which are associated with unit costs heterogeneity [4]. Nevertheless,
such characteristics are probably also correlated with the ones we did include in the analysis,
attenuating this omission. Furthermore, the extrapolation validation suggests that our
approach is robust since the models using our SDP definition successfully predict unit costs in
countries excluded from the sample.
Another limitation was the unbalanced sample size per country in our datasets (both pri-
mary and secondary). For some countries, like Kenya and South Africa, our data included
large samples, while for other countries, such as Zimbabwe and Namibia, we had access to
only a small number of facilities. The implication of this limitation is statistical, yielding differ-
ent levels of uncertainty in our estimations across settings. Once more, the validation of
VMMC unit costs’ extrapolations suggests this limitation did not compromise our approach’s
predictive ability.
Finally, our extrapolation models were limited to only a few characteristics describing both
the context and the country’s health system. Although the results show that our approach per-
formed well, more sophisticated approaches might produce better extrapolations in future
works. We used country-level characteristics describing the economy (GDP per capita and
health sector-specific salary indexes), the health system (VMMC coverage), and the epidemic
(HIV prevalence) to extrapolate unit costs to countries not included in our sample. We tested
several model specifications and chose the most robust one. However, the model specifications
we used are potentially simplistic and are undoubtedly subject to improvement as richer data
sources become available. We hope that future exercises can expand and improve upon our
approach.
In spite of these limitations, we were able to successfully standardized disparate data sets
and produce robust cost estimates for VMMC programs across the 13 critical VMMC
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countries in sub-Saharan Africa. This study provides reliable cost estimations for a wide vari-
ety of settings and can be used to help guide ongoing scale-up efforts of VMMC services in
Africa. Additionally, by applying the predictive cost modeling approach explored in this paper,
we open up the potential to expand our research to other interventions, providing accurate,
timely cost data to the program planners, policy-makers, and funders who need it.
Policy implications
Cost-effective interventions are essential to maximizing the impact of limited resources on
curbing the HIV epidemic in sub-Saharan Africa. Furthermore, funders, policy-makers, and
decision-makers all need accurate data on program implementation costs and efficiency to
inform decisions. Therefore, a timely, reliable, and accurate description of services’ unit costs
is a critical resource for them.
Our project contributes to filling the gaps in cost data in two ways. First, filling blanks; of
the 14 priority countries, there was no available data at the moment of our literature review for
8 of them (S2 Table). This paper’s supplemental material provides unit costs for all 14 priority
countries. Program managers there can use this information for planning and monitoring pur-
poses. Secondly, our approach produces a rich data set of unit costs for all the countries in the
priority list and three service delivery modalities within each country. Using this rich source of
unit costs, program directors can access more specific and nuanced cost information than pre-
viously. The cost of WMMC is not only not fixed, but it is determined by critical aspects of ser-
vice delivery that our study explicitly accounts for and examines.
Finally, our research can also be helpful for researchers developing mathematical models of
the HIV response. In cost-effectiveness analyses, estimations usually rely on highly sophisti-
cated epidemiological modeling to predict the effectiveness side of the equation. Simulta-
neously, making overly simplistic assumptions on costs -, many times a single number for
each scenario or policy alternative. This approach’s result is most likely flawed because it
depends on both the cost and the effectiveness estimations. Our results provide a rich dataset
of unit cost estimations (and confidence intervals) for three SDM in 14 countries and a model
specification to reproduce the results. We hope that this exercise will help improve modeling
efforts in the future.
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